James Frith MP: speeches

14 published records · newest first.

Speeches

  • 10 Sept 2026 · Vascular Sector Reform · Hansard source
    More

    That is a very fair and right challenge. This is not about endorsing patchwork provision; it is about understanding that, whether because of the physiological, social, environmental or behavioural differences that exist, care is not evenly distributed. We should have standards that we expect nationally, but we should also commission and empower local ICBs to commission, and we should hold them accountable through the frameworks and the work that we do in the Department.

  • 10 Sept 2026 · Vascular Sector Reform · Hansard source
    More

    It is a genuine pleasure to serve under your chairship, Dr Huq, and to join you again in Parliament. We worked together before and it is an honour to be here today. As is customary, I would like to thank the hon. Member for Strangford (Jim Shannon) for securing this important debate and for his insights. Some of us were wondering if he would write one of his famous letters of congratulations and courtesy to himself; we hope that somebody else will step up and show him the same courtesy that he affords us all by being so generous in his support of colleagues across the House. I also thank my hon. Friend the Member for Glasgow South West (Dr Ahmed), who spoke so well and with such insight, for the leadership and expertise that he showed in pulling together the Government’s ambitions for not just the 10-year plan but, as has been mentioned, the cardiovascular framework. I am of course minded to listen to anything further that he says. On his point about Scotland, he is right that I also have responsibility for the devolved nations in a seemingly ever-growing brief—he will have sympathy with me over that. I am happy to have those conversations to ensure that we learn from the Scots and that the successes here can be transported north of the non-border to which he rightly referred. The report published by the APPG earlier this year sets out suggested actions for improving vascular care. The Opposition spokesperson, the hon. Member for Solihull West and Shirley (Dr Shastri-Hurst), is right that there is much in this debate on which we agree. The calls to action include reducing waiting times, reforming commissioning, accelerating innovation, and establishing a national foot care pathway and community-based foot protection services in every local system. I commend the APPG for focusing their challenges on structural reforms and system changes, and not on simply making a new request for funding. We can all agree with the improvements the actions intend to deliver, which are, “earlier diagnosis, reduced travel and access barriers for patients, and relieving pressure on acute services by preventing deterioration and avoidable hospital admissions.” That is crucial. At the election, I was pleased to stand for a party that wanted, when in government, to bring its power and might to bear on the biggest killers. The Government very much intend to deliver those improvements through the core shifts set out in the 10-year plan for the NHS. For patients with vascular disease, that will mean fewer trips to hospital as we shift care closer to home and into the community. It will mean better use of digital technology—my hon. Friend the Member for Glasgow South West referred to the innovation part of my title, and there is more to come on that—to identify vascular disease, monitor its progression and, finally, stop it from developing or worsening. In preparation for this debate, I have been encouraged—mercifully, I am pleased to say—to use my remarks reflect the call to action from the APPG.

  • 10 Sept 2026 · Vascular Sector Reform · Hansard source
    More

    I will take any excuse I can to come to Northern Ireland, and I hope my private office has noted that. In closing, our approach to improving the treatment of vascular diseases is closely aligned with the reforms in the APPG report and the APPG’s ambitions. I know that, of course, there will be other areas in which the APPG, and the hon. Member for Strangford, will rightly continue to push for further progress. I thank hon. Members for their contributions, and I thank the APPG for its important work and report. I look forward to continued dialogue on this issue to improve the NHS, especially services for vascular disease.

  • 10 Sept 2026 · Vascular Sector Reform · Hansard source
    More

    In the humblest of terms, I would be very happy to visit and speak to my Scottish counterparts to ensure that they take that opportunity, and that any development, whether on compatibility, operability, the learnings from the NHS app in how we then develop NHS Online—that sounds a bit too much like building a website; we have to be more ambitious and describe it as what it is, which is the digitalisation of our NHS—helps to ensure that our brothers and sisters in Scotland get the same level of digital access that we expect to deliver across the NHS in England.

  • 10 Sept 2026 · Vascular Sector Reform · Hansard source
    More

    I concur fully with my hon. Friend’s point. I noted his earlier remark about the commissioning of outcomes, and I think that one of the developing themes adjoining my own thinking and my brief is the need to get better at commissioning outcomes, considering whole populations, communities and places, and determining how we spend our money based on outcomes, not just activity. My hon. Friend makes a very powerful point with his question. The hon. Member for Strangford and other members of the APPG feel strongly about the establishment of a national foot attack pathway. The Government’s ambition for integrated care boards to act as strategic commissioners focused on the needs of local populations is very much determined to assist that. The prevalence of vascular disease is not evenly distributed, as the hon. Member for North Shropshire (Helen Morgan) mentioned. ICBs are expected to use their nationally supported local commissioning power and their local data and intelligence, which includes user feedback and outcomes data, to develop a deep understanding of local need as well as local plans to develop and deliver.

  • 10 Sept 2026 · Vascular Sector Reform · Hansard source
    More

    I hope that my further remarks will address that very point; I am happy to pick it up with the hon. Member in due course if they do not satisfy. ICBs will use national modern service frameworks set by the Government and guidance to create the right services for their areas. That means local systems coming together to create neighbourhood services that reform the health and care system and are rooted in the needs of people and communities. On the issue of maximum waiting times for vascular disease, this Government recognise that it is imperative that any patient requiring a vascular assessment receives that in a timeframe that reflects their condition and enables the best possible health outcome. The Government are committed to making progress on NHS waiting times, including returning by March ’29 to the NHS constitutional standard of 92% of elective care patients’ waiting times from referral to treatment being within 18 weeks. Of course, that includes those patients waiting for vascular services. The NHS met the first interim target of 65% in March ’26, and we are now focused on driving improvements to achieve our second interim target of 70% by 2027. To help support the commitment to reduce waiting times, the podiatry workforce pipeline is currently being strengthened through NHS England’s focus programme for small and vulnerable professions, with the NHS workforce plan to be published shortly. The health service also has clear guidance on what is required in delivering services for people with vascular disease or at risk of developing it. In March ’26, NHS England published guidance on standardising community health services. That guidance identifies podiatry, diabetes and tissue viability, and wound care as core components of ICB-funded community provision. People who need urgent wound assessment—for example, those with suspected infection, rapid deterioration, or diabetic foot ulcer—should be seen within 24 hours. The guidance also makes it clear that routine assessments should occur within five to seven working days, with data collected on healing and complications. The purpose and goal of community health services must be to support people as well as to avoid their needing to be admitted to hospital and, critically, the need for amputations.

  • 10 Sept 2026 · Vascular Sector Reform · Hansard source
    More

    The hon. Member is absolutely right. We have to keep ICBs and their commissioning powers accountable to local jurisdictions. I will say a bit more on that in due course, but we are on the same page. To facilitate faster assessments we also need to speed up and make earlier diagnoses, which is why the Government plan to open four new community diagnostic centres during ’26-27. That expanding capacity will help meet our March ’29 target that no more than 1% of patients should wait over six weeks for a diagnostic test. On reforming commissioning to reward outcomes, as set out in the 10-year health plan, we want to develop new ways to pay healthcare providers based on clinical practice that maximises productivity and outcome, as my hon. Friend the Member for Glasgow South West mentioned. Under the best practice tariffs, providers receive payment when they follow agreed standards of care. On the adoption of proven innovation, the APPG report rightly identifies the importance of the NHS being able to quickly adopt new innovations. As part of my responsibility to oversee further development and enhancement of the use and usability of the NHS app, one development coming through the House at the moment is the creation of the single patient record. The future exciting development of NHS online, or digital doctor, as I might yet call it, is about the digitisation of our NHS service—embracing innovation, personalising healthcare and responsive to individual need—as well as the innovator passport, delivered through a phased approach to accelerate access to and adoption of technologies. The APPG’s report says that preventing vascular disease and its deterioration should be at the centre of the system, and I agree. Identifying people with vascular diseases and providing care centred on their needs is critical to ensuring vascular disease does not progress to the point where somebody needs incredibly serious interventions, such as a leg needing to be amputated. In this modern era, such amputations are wholly avoidable and should be prevented. The distinction between the APPG’s report and the Government’s most recent announcement of the MSF has been mentioned. I was delighted to join the British Heart Foundation yesterday at the celebration event for the MSF ahead of the delivery plan later in the year. It is a reasonable challenge to ensure that we distinguish between conditions, a point made by the Opposition spokesperson, the hon. Member for Solihull West and Shirley. It was a point made to me—and a point I thought was likely to be raised with me—by stroke and diabetes charities at the event yesterday. We are on the same page on that. He made an excellent point and challenge on the distinction that is needed. As hon. Members will know, prevention is at the heart of the Government’s health agenda—the prevention of health conditions and the prevention of them worsening. The cardiovascular disease modern service framework, which was published in July, sets a clear direction for how health and care systems should accelerate progress on the Government’s ambition to reduce premature mortality from heart disease and stroke by a quarter within a decade. My hon. Friend the Member for Broxtowe (Juliet Campbell) talked about irregularity and different areas having different levels of heart failure, which she said was four times more likely in the area she represents. I would be very happy to have conversations about how we can embrace that insight and intervene. Prevention is fundamental to the Government’s efforts around an annual heart failure review, improving access to rapid diagnosis and embedding heart failure support in cardiac rehabilitation, as well as the wider Government goal to reduce premature mortality by a quarter within the next decade. Central to the cardiovascular disease modern service framework is a holistic approach with a strong focus on reducing inequalities. The principles apply here, too: the missing millions; the need for healthy intervention and to understand the difference between the physiological, behavioural, environmental and social; an appreciation that living standards and the cost of living have as much impact as any knowledge of what to eat and when; and looking after each other. It is about commissioning for outputs, not just diktat, which means recognising that several conditions and risk factors share common causes and contribute to most heart attacks and strokes. Members have described them in their speeches: high blood pressure, smoking, diabetes, high cholesterol, unhealthy diet and lack of exercise. At its core, the framework is about a fundamental shift towards proactive, whole-person, preventive care that is located in communities and neighbourhoods and makes better use of hybrid, traditional, in-person and digital models to increase uptake and treatment. Podiatry and related foot-health services align with the shift towards local community hub delivery. The framework’s approach is backed by wider Government, including the creation of the first smoke-free generation, which began under the Conservative Government.

  • 1 Sept 2026 · Sudden Cardiac Death: Young People · Hansard source
    More

    I thank my hon. Friend for her intervention. I would be very happy to discuss those requests in person. I also pay tribute to the families of Wilson and Vicky. The impact of more and more defibs being available is incredibly important, and I am very happy to speak in more detail on that issue.

  • 1 Sept 2026 · Sudden Cardiac Death: Young People · Hansard source
    More

    I thank my hon. Friend for her intervention; I hope I will cover and do justice to those important points. NHS pathways also give providers call-level CPR data to support local reviews and improve quality, as well as reviewing data and emerging evidence to see where we must do better. They send quarterly reports to the national clinical assurance group, which is made up of senior clinicians drawn from royal colleges, professional bodies and urgent and emergency care services. These professionals can and often do submit constructive feedback on the way that pathways are run. At present, NHS clinical staff are trained in CPR, but from April 2027, this will be extended to all NHS staff, including those in A&E. The roll-out of this training will take time, but it will hugely increase the number of people in the country with valuable lifesaving knowledge. Finally, when it comes to recognising cardiac arrest, I can confirm that the Care Quality Commission does assess call handlers’ skill as part of its inspections. We know that no human system is perfect, and I am all too aware that a list or accounts like this can risk sounding defensive, so let me repeat my openness to sitting with the hon. Member for Mid Buckinghamshire, Adam’s parents and other colleagues to see how and where we can do better and go further. Turning to the hon. Member’s points about genetics, I am hugely optimistic about the potential of genomics and life sciences over the next 10 years. The NHS clinical genetics services deliver a comprehensive clinical genetics and genetic counselling service for individuals with a family history of genetic conditions, including cardiac conditions. They provide a detailed review of family history that can direct the diagnosis, risk assessment and lifelong clinical management of patients of all ages and their families who have, or are at risk of having, a genomic condition. The current specification for the clinical genetics services was published more than a decade go under the previous Government and is no longer fit for purpose, not least because this is one of the most innovative fields in healthcare. Today, specialist clinical services simply do not have the capacity or infrastructure to contact family members proactively, except where a particularly high risk has already been identified. For me and my work, it is a clear example of why innovation must help connect our public services. NHS England’s genomics programme, working with the genomics clinical reference group, has done a review of the 17 regional NHS clinical genetics services. This has shone a light on the challenges to be addressed for this service to match the Government’s expectations. I am unable to confirm a specific date for the hon. Member for Mid Buckinghamshire, but suffice to say, there is much more to be done before expectations are met by service. On his point about the UK National Screening Committee, it is true that the draft recommendations, which have been consulted on, did not find that the current scientific evidence—

  • 1 Sept 2026 · Sudden Cardiac Death: Young People · Hansard source
    More

    I am honoured to be standing at the Dispatch Box as the new Minister for Health Innovation. Let me start by thanking NHS staff for their heroic shifts over the summer months. I also thank the hon. Member for Mid Buckinghamshire (Greg Smith) for bringing this debate forward and speaking with such deep conviction. I am humbled that this is the subject of my first outing in this new role, and I thank him and other Members for their work in this important area. I know that the hon. Gentleman, through his work on the APPG, already met a previous Minister, my hon. Friend the Member for Washington and Gateshead South (Mrs Hodgson), in July. Reading about it and then listening to the hon. Gentleman’s account again in this debate, we agree that Adam’s death was an absolute tragedy. As a dad, I cannot begin to imagine what Adam’s mum and dad continue to go through, and I pay tribute to them. It goes without saying that I would of course be happy to meet with the hon. Gentleman and Adam’s parents to discuss what more we can do to change the system, to go through the seven requests in detail, and to help save other parents from the same heartbreaking loss that they have endured. I am determined that the benefits of innovation are felt first and fastest by patients and families, as quickly and safely as possible. That means accelerating the adoption of technology, digital services and the Government’s single patient record, and better integration between our national platforms, so that relevant information about known conditions, family associations and medical history can follow the person across services, professionals and organisations.

  • 1 Sept 2026 · Sudden Cardiac Death: Young People · Hansard source
    More

    I never fail to be impressed by the sheer determination of humans who have endured the worst of losses to turn such loss into a positive contribution. Without hesitation, I pay tribute to Mia’s family for their fundraising efforts. Done properly, innovation can support more joined-up care and personalised services, and faster sharing and implementation of new guidance and learning. Let me now turn to some of the specific points raised by the hon. Member for Mid Buckinghamshire. NHS England has made changes to the call script in response to new advice from Resuscitation Council UK, issued in November 2023. That advice was given just two months before Adam’s death. It is tragic that it had not yet come into force by the time that Adam stepped on to that pitch. As healthcare professionals, Adam’s mum and dad will know that those changes would have given him a much better chance of survival, as callers now receive advice to begin life support, as well as the certainty of using a defibrillator on a teenager. The hon. Gentleman raised a number of important points about the NHS pathways system. The challenge we face in improving the sensitivity of cardiac arrest identification is to do so in a way that does not generate false positives. Ongoing performance monitoring of NHS pathways finds that the system accepts over-triage; this is an intentional safety feature of triage systems. As the hon. Gentleman knows, at a time when many ambulance services are under such significant strain, the management of stretched resources is paramount. The hon. Gentleman is right in saying that NHS England works with the NHS pathways clinical team, ambulance services and specialist organisations, including Resuscitation Council UK, to review data and emerging evidence and to see where we can do better.

  • 8 Jul 2026 · Societal Impact of AI: Government Policy · Hansard source
    More

    It is a pleasure to serve under your chairship, Ms McVey. I congratulate my hon. Friend the Member for Poole (Neil Duncan-Jordan) on securing the debate, which speaks directly to the kind of country and society that we want to create for everyone we represent, and our friends and family—the type of country and society we want to live and thrive in. The Government recognise that AI is, as Members have said, already changing our economy, the delivery of public services, our expectations of each other and the ways in which we interact and engage in debate. For me, it is not merely the latest thing, or the something new and shiny that is so attractive to politics and politicians; in my mind, it is equivalent to a new atmosphere in which we now all expect to feature and play our part. We see the potential of AI in everything from scientific discovery to better public services and stronger economic growth. The Government have a clear responsibility to make sure that the change at the heart of this debate reinforces rather than weakens the fabric of our society. That includes standing up to big tech firms when we deem it necessary—examples will follow—when they facilitate harm to UK citizens. As so many Members have powerfully made the argument for, it also includes developing sovereign capability—determining what comes next and honing it for best benefit. As we bring this debate to a close, it is important that we continue to consider those questions. We must collectively decide how we build a better society in an AI-enabled world. AI must serve us, and not the other way round. The Government recognise the pressure to internationally compete on AI. That means we need to actively shape the transition towards it to secure benefits for the UK while managing risk or, as my right hon. Friend the Member for Oxford East (Anneliese Dodds) put it, exert the domestic control that we need. That is why we are working hard to ensure that the UK has the capability, access and influence it needs in the technologies that will shape our economy, public services and national security. It is why we established the sovereign AI unit with £500 million to enable the Government to back promising UK firms. The UK already attracts the third highest private investment in AI.

  • 8 Jul 2026 · Societal Impact of AI: Government Policy · Hansard source
    More

    If I am considered worthy to meet in a few weeks’ time, I will be very happy to do so. This is not about self-sufficiency or about turning away from trusted international partners; it is about ensuring that where the UK has genuine strengths—in research, talent, creativity and innovation—we can translate them into long-term economic benefit. Significant private investment is now flowing into areas that would have seemed like science fiction even a decade ago, including therapies that slow or reverse biological ageing and AI-accelerated drug discovery that could compress timelines for curing major diseases. If realised, such developments would profoundly reshape expectations of health, work and the role of the state. That is why the Government have already committed to ambitious plans to transform services and digitise government, as set out in the road map for modern digital government published earlier this year.

  • 8 Jul 2026 · Societal Impact of AI: Government Policy · Hansard source
    More

    The Government’s principle is to regulate at the time of deployment or at use. I understand the right hon. Gentleman’s argument, but it is important that we strike the right balance between innovation and regulation. Of course, as I will come on to discuss in more detail, where there have been examples of harm we must call that out and call in those who caused them. The Government have already committed to ambitious plans to transform services. For a radiologist, that means access to the best tools for detecting cancer—tools that can save lives and cut waiting lists in our NHS. The public sector is where it is perhaps most crucial that the Government ensure that we embed frameworks, standards and guidance to ensure that AI is deployed in a way that is fair, transparent and accountable. We are doing so with the data and AI ethics framework, the AI playbook, and transparency standards that ensure the public can understand how systems are used. We are also supporting UK firms that provide third-party AI-assurance ecosystems, demonstrating that AI systems are safe and reliable as well as creating new jobs. That is critical not just for risk management but for building businesses, building confidence in those deploying AI, and building trust in the systems we use. To the points that were made about the job market, AI has the potential to enhance job roles and the performance of each of us at work, but it is necessary and reasonable, as my hon. Friend the Member for Poole pointed out, to distinguish the jobs that are most at risk—those least likely to be enhanced and most likely to be replaced. That is a very reasonable proposition. We recognise that one of the primary areas where people will interact with AI is in the labour market. To zone in on labour markets, and the issue of young people and entry-level jobs, an estimated 12.8% of all people aged 16 to 24 in the UK are not in education, employment or training. That goes well beyond data-entry or access-level jobs, or a potential shift of culture in relation to entry-level jobs. To date, there is little conclusive evidence that AI is reducing employment. However, the International Monetary Fund estimates that around 70% of UK workers are in exposed occupations. Around half of those exposed workers are in high complementary roles, where AI will enhance rather than replace their work. The Government are committed to supporting the worker experience through the AI transition, and have a proud record of advancing workers’ rights. To that end, earlier this year the Government established the AI and the future of work unit, bringing together expertise from across Departments and industry to monitor how AI is affecting jobs, wages and opportunity in real time. We are putting in place the institutions, data and cross-Government co-ordination needed to ensure that AI transforms the labour market, that workers are supported and that opportunities are widely shared across society. We are also investing in people, because the opportunities of AI will be realised only if the workforce are equipped to harness them. That is why we have launched one of the most ambitious skills programmes anywhere in the world. Our AI skills boost programme is already delivering results. In an answer given to the House last week, I referred to the early careers funding and work on curriculum reforms to come, such as an AI-inclusive GCSE in computing. This is about ensuring that workers at every stage of their career, and whether in small businesses, large firms or public services, have the tools that they need to thrive in an AI-enabled economy. AI will have—is having—seismic impacts on our working lives and productivity, and we must embrace the democracy this gives us. We must democratise access to AI to ensure that communities across the country reap the benefits. Central to that effort is ensuring that support is delivered to the graduates and young people entering the world of work for the first time. Much has been made of the rising level of NEETs. Programmes such as TechLocal are creating new jobs, traineeships and professional training, while scholarships and fellowships are supporting the next generation of researchers and innovators. Nobody is waiting 25 years to tackle the threats, however. AI harms are very real, and we do not sit idly by when it comes to tackling them. We are not standing still. The AI Security Institute is conducting world-leading research to understand the capabilities and impacts of advanced AI. In response to the generation of vile and degrading non-consensual sexual deepfakes on Grok earlier this year, the Prime Minister himself, and the Government, stood up to Grok and X and won that fight. We have criminalised the creation of non-consensual sexual deepfakes and legislated to require platforms to remove them. Separately, we have banned nudification apps and criminalised AI tools designed to create sexual abuse material, as well as learning the importance of sovereignty when considering the recent switching off of the latest Anthropic AI tool. I was asked a specific question about the social media ban. I was a proud early adopter of the policy and I am pleased to say that it remains the Government’s intention to update the House before recess. The UK is proactively responding to the AI revolution—we are shaping it. AI has extraordinary potential to improve healthcare, accelerate scientific discovery, personalise education, strengthen public services and drive economic growth. We will harness the opportunities across every region and community to shape UK society for the better for all.

Published records only — not a full account of an MP’s work. How we work →